BIOTELEMETRY, INC. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016	FY2015 12 months to Dec 31, 2015
Healthcare
Research
Technology
Revenue
Cost of revenue
Gross profit
Operating expenses:
General and administrative
Sales and marketing
Bad debt expense
Research and development
Other charges
Total operating expenses
Income/(loss) from operations
Other expense:
Interest expense
Loss on extinguishment of debt
Loss on equity method investments
Other non-operating (expense)/income, net
Total other expense, net
Income/(loss) before income taxes
(Provision for)/benefit from income taxes
Net income/(loss)
Net loss attributable to noncontrolling interests
Foreign currency translation loss
Comprehensive income/(loss) attributable to BioTelemetry, Inc.
Net income/(loss) attributable to BioTelemetry, Inc.
Net income/(loss) per common share attributable to BioTelemetry, Inc.:
Basic
Diluted
Weighted average number of common shares outstanding:
Basic
Dilutive common stock equivalents
Diluted
Anti-dilutive stock options and restricted stock units excluded from weighted average calculation (in shares)

Comments